186 related articles for article (PubMed ID: 31612222)
21. Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2.
Aimová D; Poljaková J; Kotrbová V; Moserová M; Frei E; Arlt VM; Stiborová M
Interdiscip Toxicol; 2008 Sep; 1(2):160-8. PubMed ID: 21218107
[TBL] [Abstract][Full Text] [Related]
22. Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats.
Stiborová M; Dračínská H; Bořek-Dohalská L; Klusoňová Z; Holecová J; Martínková M; Schmeiser HH; Arlt VM
Toxicology; 2018 May; 400-401():48-56. PubMed ID: 29649501
[TBL] [Abstract][Full Text] [Related]
23. Comparison of human cytochrome P450 1A1-catalysed oxidation of benzo[
Stiborová M; Indra R; Moserová M; Bořek-Dohalská L; Hodek P; Frei E; Kopka K; Schmeiser HH; Arlt VM
Monatsh Chem; 2017; 148(11):1959-1969. PubMed ID: 29104317
[TBL] [Abstract][Full Text] [Related]
24. Modulation of human cytochrome P450 1A1-mediated oxidation of benzo[a]pyrene by NADPH:cytochrome P450 oxidoreductase and cytochrome b5.
Indra R; Moserova M; Kroftova N; Sulc M; Martinkova M; Adam V; Eckschlager T; Kizek R; Arlt VM; Stiborova M
Neuro Endocrinol Lett; 2014; 35 Suppl 2():105-13. PubMed ID: 25638374
[TBL] [Abstract][Full Text] [Related]
25. Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cells.
Heintze T; Klein K; Hofmann U; Zanger UM
Sci Rep; 2021 Jan; 11(1):1000. PubMed ID: 33441761
[TBL] [Abstract][Full Text] [Related]
26. In vitro mechanistic differences in benzo[a]pyrene-DNA adduct formation using fish liver and mussel digestive gland microsomal activating systems.
Peters LD; Telli-Karakoç F; Hewer A; Phillips DH
Mar Environ Res; 2002; 54(3-5):499-503. PubMed ID: 12408608
[TBL] [Abstract][Full Text] [Related]
27. Diallyl Trisulfide Enhances Benzo[
Uno S; Sakai M; Fujinari Y; Hosono T; Seki T; Makishima M
Anticancer Res; 2019 May; 39(5):2369-2375. PubMed ID: 31092429
[TBL] [Abstract][Full Text] [Related]
28. Effect of hepatic cytochrome P450 (P450) oxidoreductase deficiency on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adduct formation in P450 reductase conditional null mice.
Arlt VM; Singh R; Stiborová M; Gamboa da Costa G; Frei E; Evans JD; Farmer PB; Wolf CR; Henderson CJ; Phillips DH
Drug Metab Dispos; 2011 Dec; 39(12):2169-73. PubMed ID: 21940903
[TBL] [Abstract][Full Text] [Related]
29. Pregnane X receptor regulates the AhR/Cyp1A1 pathway and protects liver cells from benzo-[α]-pyrene-induced DNA damage.
Cui H; Gu X; Chen J; Xie Y; Ke S; Wu J; Golovko A; Morpurgo B; Yan C; Phillips TD; Xie W; Luo J; Zhou Z; Tian Y
Toxicol Lett; 2017 Jun; 275():67-76. PubMed ID: 28428138
[TBL] [Abstract][Full Text] [Related]
30. Benzo[a]pyrene and Caenorhabditis elegans: defining the genotoxic potential in an organism lacking the classical CYP1A1 pathway.
Abbass M; Chen Y; Arlt VM; Stürzenbaum SR
Arch Toxicol; 2021 Mar; 95(3):1055-1069. PubMed ID: 33420596
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of β-catenin signalling promotes DNA damage elicited by benzo[a]pyrene in a model of human colon cancer cells via CYP1 deregulation.
Kabátková M; Zapletal O; Tylichová Z; Neča J; Machala M; Milcová A; Topinka J; Kozubík A; Vondráček J
Mutagenesis; 2015 Jul; 30(4):565-76. PubMed ID: 25805023
[TBL] [Abstract][Full Text] [Related]
33. Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line.
de Waard PW; de Kok TM; Maas LM; Peijnenburg AA; Hoogenboom RL; Aarts JM; van Schooten FJ
Mutagenesis; 2008 Jan; 23(1):67-73. PubMed ID: 18065724
[TBL] [Abstract][Full Text] [Related]
34. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
Shiizaki K; Kawanishi M; Yagi T
Mutat Res; 2013 Jan; 750(1-2):77-85. PubMed ID: 23036853
[TBL] [Abstract][Full Text] [Related]
35. Effect of low-level short-term o-xylene inhalation of benzo[a]pyrene (BaP) metabolism and BaP-DNA adduct formation in rat liver and lung microsomes.
Park SH; Schatz RA
J Toxicol Environ Health A; 1999 Nov; 58(5):299-312. PubMed ID: 10598955
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells.
Takemura H; Nagayoshi H; Matsuda T; Sakakibara H; Morita M; Matsui A; Ohura T; Shimoi K
Toxicology; 2010; 274(1-3):42-8. PubMed ID: 20553787
[TBL] [Abstract][Full Text] [Related]
37. Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels.
Uno S; Dalton TP; Shertzer HG; Genter MB; Warshawsky D; Talaska G; Nebert DW
Biochem Biophys Res Commun; 2001 Dec; 289(5):1049-56. PubMed ID: 11741297
[TBL] [Abstract][Full Text] [Related]
38. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
[TBL] [Abstract][Full Text] [Related]
39. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation.
Uno S; Dalton TP; Derkenne S; Curran CP; Miller ML; Shertzer HG; Nebert DW
Mol Pharmacol; 2004 May; 65(5):1225-37. PubMed ID: 15102951
[TBL] [Abstract][Full Text] [Related]
40. Suppressive effect of 1-nitropyrene on benzo[a]pyrene-induced CYP1A1 protein expression in HepG2 cells.
Cherng SH; Hsu SL; Yang JL; Yu CT; Lee H
Toxicol Lett; 2006 Mar; 161(3):236-43. PubMed ID: 16280210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]